From: Favorable intermediate risk prostate cancer with biopsy Gleason score of 6
 | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
HR | 95%CI | p-value | HR | 95%CI | p-value | |
Age | 0.967 | 0.911–1.027 | 0.274 |  |  |  |
Bdoy mass index | 1.116 | 0.962–1.295 | 0.148 |  |  |  |
DM | 0.314 | 0.042–2.327 | 0.257 |  |  |  |
HTN | 1.854 | 0.793–4.335 | 0.154 |  |  |  |
Prostate volume | 0.953 | 0.921–0.986 | 0.005 | 0.956 | 0.923–0.991 | 0.013 |
PSA | 1.043 | 0.907–1.199 | 0.555 |  |  |  |
PSA density | 14.810 | 2.307–95.077 | 0.004 |  |  |  |
PIRADS (< 3 vs. ≥ 3) | 3.002 | 1.024–8.800 | 0.035 | 2.595 | 1.949–7.098 | 0.043 |
Number of biopsy (12 vs. ≥ 13) | 1.162 | 0.422–3.202 | 0.772 |  |  |  |
Mean percentage of positive core | 1.022 | 0.005–1.040 | 0.012 | 1.345 | 0.632–2.863 | 0.442 |
Mean tumor length | 2.114 | 0.786–5.681 | 0.138 |  |  |  |
Mean percentage of total tumor of core | 1.012 | 0.997–1.027 | 0.117 |  |  |  |